Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-01-05

FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for desipramine hydrochloride (Actavis Pharma, Inc.), updating the labeling for the product under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DESIPRAMINE HYDROCHLORIDE (Desipramine hydrochloride)

Snippet

SUPPL AP for DESIPRAMINE HYDROCHLORIDE (DESIPRAMINE HYDROCHLORIDE)